Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$3.91
-0.25-6.05%
At close: May 7, 5:00 PM EST
$4.00
0.08992.30%
After Hours: 4:08 PM EST
Purple Biotech Ltd Analyst Ratings
PPBTNASDAQ
Purple Biotech Analyst Ratings and Price Targets | NASDAQ:PPBT | Benzinga
Purple Biotech Ltd has a consensus price target of $15 based on the ratings of 4 analysts. The high is $30 issued by HC Wainwright & Co. on March 13, 2026. The low is $8 issued by JonesTrading on July 21, 2023. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on March 13, 2026, November 15, 2024, and September 20, 2024, respectively. With an average price target of $32 between HC Wainwright & Co., there's an implied 700.00% upside for Purple Biotech Ltd from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Chardan Capital
JonesTrading
Chardan Capital
1calculated from analyst ratings
Analyst Ratings for Purple Biotech
Loading calendar...
FAQ
What is the target price for Purple Biotech (PPBT) stock?
The latest price target for Purple Biotech (NASDAQ:PPBT) was reported by HC Wainwright & Co. on March 13, 2026. The analyst firm set a price target for $30.00 expecting PPBT to rise to within 12 months (a possible 650.00% upside). 1 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Purple Biotech (PPBT)?
The latest analyst rating for Purple Biotech (NASDAQ:PPBT) was provided by HC Wainwright & Co., and Purple Biotech maintained their buy rating.
When was the last upgrade for Purple Biotech (PPBT)?
There is no last upgrade for Purple Biotech
When was the last downgrade for Purple Biotech (PPBT)?
There is no last downgrade for Purple Biotech.
When is the next analyst rating going to be posted or updated for Purple Biotech (PPBT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Purple Biotech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Purple Biotech was filed on March 13, 2026 so you should expect the next rating to be made available sometime around March 13, 2027.
Is the Analyst Rating Purple Biotech (PPBT) correct?
While ratings are subjective and will change, the latest Purple Biotech (PPBT) rating was a maintained with a price target of $34.00 to $30.00. The current price Purple Biotech (PPBT) is trading at is $4.00, which is out of the analyst’s predicted range.
